Nurix Therapeutics Inc [NRIX]
Pivotdata
Pivotstatistikk
| Måltall | Snitt | Median | Std.avvik |
|---|---|---|---|
| Gevinst % | 32.51% | 29.51% | 25.43% |
| Tap % | -17.65% | -15.47% | 11.35% |
| Varighet | 20.3d | 16d | 15.1d |
| Totalt antall pivoter | 46 |
| Gevinst-/tapsbein | 45 (22 Gevinst / 23 Tap) |
| Siste pivot | Top @ $17.76 den 2026-05-29 |
| Endring siden siste pivot | $-0.72 (-4.05%) |
Neste pivotprognose Siste: $17.04
| Forventet neste type | Bottom |
| Forventet pris (snitt) | $14.63 |
| Forventet pris (median) | $15.01 |
| Forventet prisintervall (~68%) | $12.61 - $16.64 |
| Endring til snittmål | $-2.41 (-14.17%) |
| Forventet dato (snitt) | 2026-06-18 |
| Forventet datointervall (~68%) | 2026-06-03 - 2026-07-03 |
| Grunnlag | Based on 23 historical losses (Avg: -17.65%, Median: -15.47%, StdDev of Abs: 11.35%) and duration (Avg: 20.3 days, StdDev: 15.1 days) |
| Merk | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Nurix Therapeutics Inc gained modestly, up 0.53%.
Nurix Therapeutics Inc (NRIX) stock price advanced on Monday after the stock rose $0.0900 (0.53%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 3.07% rise. With 2.68M shares traded, volume yesterday reached $45.70M. This was 118 926 shares more than the prior day. Compared to the 10-day average of 4.33M shares, volume was the same as the average.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (23.3%), medium- (23.3%), and long-term (23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $17.50. approximately $0.460 (2.70%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -
Nurix Therapeutics Inc Evaluation
- Kort score: 1.22
- Medium score: 3.09
- Lang score: 2.92